Trinity Capital (TRIN) Appoints Michael Testa as CFO

Trinity Capital Inc. (Nasdaq: TRIN) today announced that, as part of the Company's long-term succession plan, its Board of Directors has named Michael Testa as Chief Financial Officer ("CFO"), effective immediately. He succeeds David Lund, who will remain on the team as a consultant, focusing on strategic growth initiatives for the Company.

Mr. Testa joined Trinity Capital in 2020 as Chief Accounting Officer ("CAO"). Prior to joining Trinity, he served as Vice President and Controller at Oxford Funds, a credit-focused asset manager, and worked within the financial services practice of Ernst & Young LLP, focusing on financial audits of clients in the asset management industry.

"Michael has played an integral part in our success over the past four years in his role as CAO, and we are excited to see his leadership continue to impact Trinity during our next phase of growth," said Kyle Brown, Chief Executive Officer of Trinity Capital. "On behalf of the entire team at Trinity, I would like to thank David for his leadership as CFO over the last four years, including his important contributions toward the Company's initial public offering in 2021 and the subsequent enterprise growth he helped drive."

"I would like to congratulate Michael on his appointment as CFO," said David Lund, who served as Trinity's CFO since November 2020 and has had a decorated career as a leader at various companies. "After working closely together over the last several years, it's clear Michael is the right person to now lead Trinity's finance and accounting functions."

"I am honored to be stepping into the role of CFO," said Michael Testa. "I look forward to partnering with Kyle and the rest of the management team to expand the Trinity platform and work to deliver long-term, accretive value for our shareholders."

You May Also Be Interested In

• Exclusive: SB Energy Nasdaq IPO moving forward as planned
• Curtiss-Wright names COO Rayment as next CEO, effective 2027
• XFLH Capital Corporation Announces the Signing of a Letter of Intent with Renogen Biolab Inc.